•Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort
•Randomized trial comparing 5-year follow-up of first-line infliximab to conventional therapy in paediatric Crohn's disease
•FCGR2A promoter variant reveals shared genetic susceptibility between IBD and stroke
•The implementation of mindfulness-based cognitive therapy for patients with inflammatory bowel disease: a qualitative study
•Kaempferitrin attenuates DSS-induced colitis by promoting ubiquitination-mediated degradation of the nuclear factor kappa B p65
